Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-24

Clinical Trial Update: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

View source ↗

Summary

A ClinicalTrials.gov update describes a biospecimen collection study led by TScan Therapeutics to identify targets of disease-reactive T cells in autoimmune dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: TScan Therapeutics, Inc. | Conditions: Autoimmune Diseases, Ulcerative Colitis | Status: RECRUITING